Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sotera Health CoSHC · Entity 3869 | Director · Executive Chairman | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sotera Health Co
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivative | Direct | 397,912 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 294,515 · Balance 397,912 F1: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Common StockSEC Table I · non-derivative | IndirectBy Grantor Trust | 3,969,393 |
Reported balance
After 2026-08-17 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-17 · Sale · Disposed 850,000 · Balance 3,969,393 F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 19, 2026 20:24 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock | 850,000 | $18.50 | $15,725,935.00 |
DisclosureSEC source: 0001193125-26-356962 · ownership.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Grantor Trust Disclosed balance after: 3,969,393 F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 20:24 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 294,515 | $18.50 | $5,448,851.47 |
DisclosureSEC source: 0001193125-26-356962 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,912 F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | GrantShare Appreciation Units · Derivative | 120,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · derivative · entry 9 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,124 Underlying: Common Stock · 120,124 shares Expires not disclosed F7 · derivative.exercise_price: These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance. F7 · derivative.exercise_date: These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance. F7 · derivative.expiration_date: These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | Exercise / conversionShare Appreciation Units · Derivative | 89,686 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · derivative · entry 8 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,790 Underlying: Common Stock · 89,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · price: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · derivative.exercise_date: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · derivative.expiration_date: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock | 240,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 6 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,427 F6 · shares: These securities consist of RSUs that were granted on March 2, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 79,104 | $15.91 | $1,258,544.64 |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 5 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,179 F5 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 179,372 RSUs granted to the Reporting Person on March 3, 2025. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 39,552 | $15.91 | $629,272.32 |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 4 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531,283 F4 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 89,686 SAUs granted to the Reporting Person on March 3, 2025. This award was granted pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to recieve one share of Common Stock, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | Exercise / conversionCommon Stock | 89,686 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · price: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 40,302 | $15.91 | $641,204.82 |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 481,149 F2 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 91,386 RSUs granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:17 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 31,339 | $15.91 | $498,603.49 |
DisclosureSEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,451 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 Restricted Stock Units ("RSUs") granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:43 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock | 39,243 | $16.45 | $645,547.35 |
DisclosureSEC source: 0001193125-25-314343 · ownership.xml · nonDerivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:43 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock | 394,861 | $16.45 | $6,495,463.45 |
DisclosureSEC source: 0001193125-25-314343 · ownership.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Grantor Trust Disclosed balance after: 4,819,393 Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:43 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 315,896 | $16.45 | $5,196,489.20 |
DisclosureSEC source: 0001193125-25-314343 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 552,790 Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 02:49 UTC | Sotera Health Co SHC · Entity 3869 | GrantPerformance Stock Units · Derivative | 149,476 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032994 · ownership.xml · derivative · entry 7 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,476 Underlying: Common Stock · 149,476 shares Expires not disclosed F7 · derivative.exercise_price: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. F7 · shares: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. F7 · derivative.exercise_date: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. F7 · derivative.expiration_date: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 02:49 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock | 298,953 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 4 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 868,603 F4 · shares: These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026. F5 · balance_after: These securities consist of 552,790 RSUs and 315,813 shares of Common Stock. Read SEC document |
| March 02, 2025 Filed Mar 5, 2025 02:49 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 40,987 | $12.47 | $511,107.89 |
DisclosureSEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,650 F3 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 91,386 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2025 Filed Mar 5, 2025 02:49 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 31,872 | $12.47 | $397,443.84 |
DisclosureSEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,637 F2 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2025 Filed Mar 5, 2025 02:49 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 27,990 | $12.47 | $349,035.30 |
DisclosureSEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 642,509 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,407 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| November 22, 2024 Filed Nov 22, 2024 22:50 UTC | Sotera Health Co SHC · Entity 3869 | GiftCommon Stock, $0.01 par value per share ("Common Stock") | 39,243 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-130309 · ownership.xml · nonDerivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 39,243 F3 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 22, 2024 Filed Nov 22, 2024 22:50 UTC | Sotera Health Co SHC · Entity 3869 | GiftCommon Stock, $0.01 par value per share ("Common Stock") | 39,243 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-130309 · ownership.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Grantor Trust Disclosed balance after: 5,214,337 Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 22:50 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 29,250 | $13.21 | $386,392.50 |
DisclosureSEC source: 0000950170-24-130309 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670,499 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. F2 · balance_after: These securities consist of 478,693 RSUs and 191,806 shares of Common Stock. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:18 UTC | Sotera Health Co SHC · Entity 3869 | GiftCommon Stock, $0.01 par value per share ("Common Stock") | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-105933 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Grantor Trust Disclosed balance after: 5,253,580 F1 · shares: Represents a gift of issuer securities by the reporting person to a charitable foundation. The recipient of the gifted securities has executed a lock-up agreement equivalent to the lock-up agreement entered into with respect to the September 6, 2024 registered stock offering. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:35 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 544,509 | $0.00 Strike: $14.59 | $0.00 |
DisclosureSEC source: 0000950170-24-026347 · ownership.xml · derivative · entry 5 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544,509 Underlying: Common Stock · 544,509 shares Expires 2034-03-04 F7 · derivative.exercise_date: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions. F7 · balance_after: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:35 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 1,003,870 | $14.31 | $14,362,870.03 |
DisclosureSEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 4 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Grantor Trust Disclosed balance after: 5,453,580 F5 · shares: On March 4, 2024, the Reporting Person sold a total of 1,003,870 shares of Common Stock of the Issuer in an underwritten public secondary offering (the "Offering"). F6 · price: Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the Issuer's Prospectus 424(b)(7), filed with the United States Securities and Exchange Commission on February 29, 2024. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:35 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 274,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,749 F3 · shares: These securities consist of RSUs that were granted on March 4, 2024, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing March 2, 2025. F4 · balance_after: These securities consist of 543,910 RSUs and 155,839 shares of Common Stock. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:35 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 21,574 | $14.56 | $314,117.44 |
DisclosureSEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 425,589 F2 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:35 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 27,990 | $14.56 | $407,534.40 |
DisclosureSEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,163 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,406 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 21:08 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 29,250 | $13.93 | $407,452.50 |
DisclosureSEC source: 0001822479-23-000070 · wk-form4_1700687309.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 555,418 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. F2 · price: Represents the closing price of the Company's Common Stock on November 20, 2023. F3 · balance_after: These securities consist of 403,219 RSUs and 152,199 shares of Common Stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:35 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 404,094 | $0.00 Strike: $17.59 | $0.00 |
DisclosureSEC source: 0001822479-23-000021 · wf-form4_167831492828392.xml · derivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,094 Underlying: Common Stock · 404,094 shares Expires 2033-03-06 F4 · derivative.exercise_date: These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2024, subject to vesting conditions. F4 · balance_after: These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2024, subject to vesting conditions. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:35 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 213,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001822479-23-000021 · wf-form4_167831492828392.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584,668 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 6, 2023, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing March 2, 2024. F2 · balance_after: These securities consist of 468,436 RSUs and 116,232 shares of Common Stock. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:47 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 19,841 | $17.41 | $345,431.81 |
DisclosureSEC source: 0001822479-23-000017 · wf-form4_167814642447695.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,479 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,406 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. F2 · price: Represents the closing price of the Company's Common Stock on March 2, 2023. F3 · balance_after: These securities consist of 255,247 RSUs and 116,232 shares of Common Stock. Read SEC document |
| November 20, 2022 Filed Nov 22, 2022 22:00 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 29,251 | $6.02 | $176,091.02 |
DisclosureSEC source: 0001822479-22-000080 · wf-form4_166915442637925.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,320 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,218 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. F2 · price: Represents the closing price of the Company's Common Stock on November 18, 2022. F3 · balance_after: These securities consist of 317,653 RSUs and 73,667 shares of Common Stock. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:20 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 2,108,356 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001822479-22-000078 · wf-form4_166803242535825.xml · derivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,108,356 Underlying: Common Stock · 2,108,356 shares Expires 2032-11-07 F3 · derivative.exercise_date: These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). The options vest in three installments, as follows: 30%, 30%, and 40% of the options vest on each of the 12-month, 18-month, and 24-month anniversaries, respectively, of the date of grant, subject to the Reporting Person's continued service through each such date. F3 · balance_after: These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). The options vest in three installments, as follows: 30%, 30%, and 40% of the options vest on each of the 12-month, 18-month, and 24-month anniversaries, respectively, of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:13 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 478,932 | $0.00 Strike: $20.03 | $0.00 |
DisclosureSEC source: 0001822479-22-000019 · wf-form4_164642836722086.xml · derivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,932 Underlying: Common Stock · 478,932 shares Expires 2032-03-02 F4 · derivative.exercise_date: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. F4 · balance_after: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:13 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 187,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001822479-22-000019 · wf-form4_164642836722086.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,571 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 2, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. F2 · balance_after: These securities consists of 382,871 RSUs and 37,700 shares of Common Stock. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 01:00 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 27,517 | $22.54 | $620,233.18 |
DisclosureSEC source: 0001822479-21-000076 · wf-form4_163771559892577.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,352 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. F2 · balance_after: These securities consists of 195,652 RSUs and 37,700 shares of Common Stock. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:34 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 817,439 | $26.12 | $21,353,550.28 |
DisclosureSEC source: 0001628280-21-005471 · wf-form4_161661805855061.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Grantor Trust Disclosed balance after: 6,377,185 F1 · shares: On March 22, 2021, Mr. Petras sold a total of 817,439 shares of Common Stock of Sotera Health Company in an underwritten public secondary offering (the "Offering"). F2 · price: Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the company's Prospectus 424(b)(4), filed with the United States Securities and Exchange Commission on March 18, 2021. Read SEC document |
| November 24, 2020 Filed Nov 24, 2020 23:56 UTC | Sotera Health Co SHC · Entity 3869 | Disposition to issuerCommon Stock | 946,102 | $21.68 | $20,511,491.36 |
DisclosureSEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 3 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Grantor Trust Disclosed balance after: 7,194,624 F2 · price: Reflects a company repurchase price equal to the initial public offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the company's Registration Statement on Form S-1. Read SEC document |
| November 24, 2020 Filed Nov 24, 2020 23:56 UTC | Sotera Health Co SHC · Entity 3869 | Disposition to issuerCommon Stock | 437,821 | $21.68 | $9,491,959.28 |
DisclosureSEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 2 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Grantor Retained Annuity Trust Disclosed balance after: 0 F2 · price: Reflects a company repurchase price equal to the initial public offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the company's Registration Statement on Form S-1. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:56 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 1,118,012 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032076 · doc4.xml · derivative · entry 4 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118,012 Underlying: Common Stock · 1,118,012 shares Expires 2030-11-20 F3 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:56 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 260,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 1 Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,869 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.